why choose us

First received: January 31, 2023

Clinical Trial: Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Kidney Diseases

Study Type: INTERVENTIONAL


Official Title: Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Brief Summary: The goal of this study is to better understand the effects of a sodium-glucose transport protein 2 inhibitor, dapagliflozin, added on to standard of care on heart and lung function and circulating metabolites (substances created when our bodies break down food, drugs, or its own tissues) in patients with chronic kidney disease.

Read more